PrimeRFP SCOUT · Federal Contract Recompete Brief

36E79722N0013Estimated delivery ORDER for the omeprazole — Golden State Medical Supply, Inc

PoP ended Mar 31, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Nac Pharmaceuticals (36E797)
Awarding office
Golden State Medical Supply, Inc
Recipient
Mar 31, 2022
PoP end
$356K
Obligated
$356K
Potential
325412
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Golden State Medical Supply, Inc — $90

Contract facts

Federal
Contract number36E79722N0013
Also listed as36E797-22-N-0013
Also listed as36E79720D0014-36E79722N0013
AgencyNac Pharmaceuticals (36E797)
Awarding officeNac Pharmaceuticals (36E797)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentGolden State Medical Supply, Inc
CAGE1HT23
UEIGQLDJJ8AQNN5
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36E79720D0014
Place of performanceCAMARILLO CA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startFeb 7, 2022
PoP end (current)Mar 31, 2022
Obligated$356K
Current value$356K
Potential value$356K

ESTIMATED DELIVERY ORDER FOR THE OMEPRAZOLE 20 MG FOR THE PHARM REPACKAGING PROGRAM FOR FEBRUARY 2022 is a federal award for Nac Pharmaceuticals (36E797) held by Golden State Medical Supply, Inc. Estimated value $356K ($356K obligated). Current period of performance ends Mar 31, 2022. Place of performance: CAMARILLO CA.

ESTIMATED DELIVERY ORDER FOR THE OMEPRAZOLE 20 MG FOR THE PHARM REPACKAGING PROGRAM FOR FEBRUARY 2022

Recompete timing

Public
Past PoP end (1604 days ago)

Current PoP ended Mar 31, 2022 (1604 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Explore more pipelines →

Frequently asked questions

What is contract 36E79722N0013?

36E79722N0013 (Estimated delivery ORDER for the omeprazole) is a Nac Pharmaceuticals (36E797) award with a potential value of $356K, currently held by Golden State Medical Supply, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36E797-22-N-0013?

36E797-22-N-0013 is the dashed form of PIID 36E79722N0013 (Estimated delivery ORDER for the omeprazole), held by Golden State Medical Supply, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36E79722N0013?

Nac Pharmaceuticals (36E797) awarded 36E79722N0013 to Golden State Medical Supply, Inc (potential $356K).

Who is the incumbent on 36E79722N0013?

Golden State Medical Supply, Inc is the incumbent. The current period of performance ends Mar 31, 2022.

When does Golden State Medical Supply, Inc’s 36E79722N0013 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 31, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36E79722N0013